YZi Labs: Web3’s New Playground 🚀

by

In the shadow of towering servers and caffeine-fueled nights, YZi Labs (formerly known as Binance Labs, but let’s not dwell on the past) has birthed Season 2 of its EASY Residency. This eight-week odyssey promises to arm Web3, AI, and biotech entrepreneurs with enough mentorship, capital, and global connections to make even a startup’s dreams feel plausible. Or at least profitable.

From October 6, 2025, to December 5, 2025, the residency will unfold like a well-rehearsed drama, complete with visa hurdles overcome and cities added to the itinerary. Dubai, San Francisco, New York, and Singapore-four hubs where founders can finally forget their passport numbers. Dubai, the central stage, will host the demo day during Binance Blockchain Week, because nothing says “global” like a week-long event named after a blockchain.

✨ @EASYResidency Season 2 – We’re Live!

Where Web3, AI, and Biotech founders build without borders.

Seven years in the making. (Spoiler: It’s still not finished.)

Now launching across four cities worldwide. 🌍

See our opening day recap 🧵👇

– YZi Labs (@yzilabs) October 17, 2025

The program, a symphony of workshops, lectures, and in-person events, will stitch together these cities into a tapestry of collaboration. Or, as the founders might call it, “a chance to avoid Zoom fatigue.” Participants will also gain access to the BNB Chain’s MVB accelerator, a program that’s been around long enough to have forgotten its own acronym.

For those lucky enough to be accepted, the prize is $500,000 in funding. That’s $150,000 for 5% equity (because who doesn’t love a good SAFE?) plus $350,000 on an uncapped SAFE. The mentors? A who’s who of crypto royalty: CZ, Vitalik Buterin, Sandeep Nailwal, and Matt Huang. They’ll offer wisdom on scaling startups, leadership, and perhaps how to avoid regulatory scrutiny.

The curriculum? Stablecoins, payments, Web3 tools, agentic AI, and gene therapy. Because why fix what’s broken when you can revolutionize it. The participants will emerge not just as founders, but as modern-day alchemists, turning code into cash and DNA into dividends. Or maybe they’ll just get really good at pitching. Either way, the world awaits their next big idea-or at least their next press release.

Read More

2025-10-17 17:08